Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than ...
The Trump administration is tearing down both regulations and the federal government that enforces them. The consequences will be enormous.
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
The United States does have the highest drug prices in the ... called Trikafta that was approved by the FDA in 2019 can cost up to $300,000 per patient per year, while the manufacturing cost ...
The US Food and Drug Administration ... people die each day while waiting for a kidney, according to the National Kidney Foundation. United Therapeutics’ goal is to increase the number of ...
--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ... approved treatments may require eye injections as often as once ...
For the first time in over two decades, the U.S. Food and Drug Administration has approved a new kind of non-opioid drug ... and fatal overdose in Georgia is estimated at $21 million per year. This ...
US Federal officials have approved a new pain pill by Vertex ... medication. (AP) The drug will be priced at $15.50 per pill, making it significantly more expensive than opioids, which are often ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.